← FDA Drug Approvals (Drugs@FDA)

EPTIFIBATIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2015-06-12

Drug application

FDA Application #

ANDA090854

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPTIFIBATIDE

Generic name

Eptifibatide

Active ingredients

EPTIFIBATIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

First approval

2015-06-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown